![\"\"](\"https:\/\/neutrale.al\/wp-content\/uploads\/2023\/01\/ED650328-F5EB-4B8F-87A1-A409B387AEFF-207x300.jpeg\")
<\/p>\nMbr\u00ebmjen e s\u00eb premtes von\u00eb, mesazhi erdhi nga Agjencia Amerikane e Barnave, FDA. <\/p>\n
N\u00eb pak m\u00eb shum\u00eb se dy jav\u00eb, ai mund t\u00eb dal\u00eb n\u00eb treg n\u00eb vend.
\nNj\u00eb ila\u00e7 i ri suedez q\u00eb duhet t\u00eb jet\u00eb n\u00eb gjendje t\u00eb ngadal\u00ebsoj\u00eb s\u00ebmundjen e Alzheimerit \u00ebsht\u00eb vler\u00ebsuar n\u00eb Shtetet e Bashkuara.
\nNj\u00eb ila\u00e7 i ri suedez q\u00eb duhet t\u00eb jet\u00eb n\u00eb gjendje t\u00eb ngadal\u00ebsoj\u00eb s\u00ebmundjen e Alzheimerit \u00ebsht\u00eb vler\u00ebsuar n\u00eb Shtetet e Bashkuara.<\/p>\n
Ila\u00e7i i frenave Lecanemab, i cili do t\u00eb dal\u00eb me emrin e mark\u00ebs Leqembi, u miratua me shpejt\u00ebsi n\u00eb Shtetet e Bashkuara.
\n“Aprovimi nga FDA i Leqembit n\u00ebn procedur\u00ebn e p\u00ebrshpejtuar \u00ebsht\u00eb nj\u00eb moment historik i r\u00ebnd\u00ebsish\u00ebm jo vet\u00ebm p\u00ebr Bioarctic dhe partnerin ton\u00eb Eisai, por p\u00ebr t\u00eb gjith\u00eb fush\u00ebn e k\u00ebrkimit, si dhe p\u00ebr pacient\u00ebt, t\u00eb af\u00ebrmit dhe kujdestar\u00ebt q\u00eb tani mund t\u00eb p\u00ebrfitojn\u00eb nga m\u00eb shum\u00eb se 20 vjet k\u00ebrkime. dhe zhvillimi q\u00eb q\u00ebndron pas k\u00ebtij progresi\u201d, thot\u00eb CEO i Bioarctic, Gunilla Osswald.
\nLecanemab, i cili ngadal\u00ebson r\u00ebnien njoh\u00ebse n\u00eb s\u00ebmundjen e but\u00eb Alzheimer, \u00ebsht\u00eb zhvilluar n\u00eb nj\u00eb bashk\u00ebpunim midis Bioarctic suedeze dhe kompanis\u00eb farmaceutike japoneze Eisai.
\nLars Lannfelt \u00ebsht\u00eb nj\u00eb mjek dhe profesor i lart\u00eb n\u00eb Universitetin Uppsala.
\nLars Lannfelt \u00ebsht\u00eb nj\u00eb mjek dhe profesor i lart\u00eb n\u00eb Universitetin Uppsala.<\/p>\n
Kjo ndodh pasi Lars Lannfelt, profesor n\u00eb Universitetin Uppsala, mori iden\u00eb n\u00eb vitin 1999 p\u00ebr t\u00eb zhvilluar nj\u00eb antitrup q\u00eb synon protofilluesit. Protofillers jan\u00eb nj\u00eb pararend\u00ebs i tretsh\u00ebm i fibrileve, t\u00eb cilat formojn\u00eb pllakat n\u00eb tru.
\n– Ne e prodhuam antitrupin n\u00eb vitin 2005 n\u00eb laboratorin tim n\u00eb Uppsala dhe q\u00eb at\u00ebher\u00eb kemi bashk\u00ebpunuar me kompanin\u00eb farmaceutike japoneze Eisai.
\nAi e p\u00ebrshkruan at\u00eb si nj\u00eb antitrup q\u00eb hyn dhe aktivizon “makinerin\u00eb e pastrimit” t\u00eb trurit q\u00eb pastron dhe heq pllak\u00ebn.<\/p>\n
Ila\u00e7i i ri i frenave mban emrin Leqembi.<\/p>\n
Trajtimi me Leqembi u jepet n\u00eb m\u00ebnyr\u00eb intravenoze \u00e7do dy jav\u00eb pacient\u00ebve me d\u00ebmtim t\u00eb leht\u00eb kognitiv ose s\u00ebmundje t\u00eb leht\u00eb Alzheimer.
\nP\u00ebr t\u00eb shmangur \u00ebnjtjen e trurit, nj\u00eb nga efektet an\u00ebsore t\u00eb njohura, FDA rekomandon q\u00eb pacient\u00ebt t\u00eb ndiqen vazhdimisht me nj\u00eb MRI.<\/p>\n
Miratimi i kusht\u00ebzuar i FDA-s\u00eb bazohet n\u00eb studimin e Faz\u00ebs II t\u00eb Clarity AD, i cili zgjati 18 muaj. Ai p\u00ebrfshinte 1,795 pacient\u00eb me s\u00ebmundjen e hershme t\u00eb Alzheimerit midis mosh\u00ebs 50 dhe 90 vje\u00e7.
\n\u00c7mimi i Leqembit \u00ebsht\u00eb vendosur rreth 25,000 SEK n\u00eb muaj.
\n\u00cbsht\u00eb e paqart\u00eb se kur ila\u00e7i i frenave mund t\u00eb jet\u00eb i disponuesh\u00ebm n\u00eb tregun evropian.
\nMezi nj\u00eb muaj m\u00eb par\u00eb, Lars Lannfelt i tha Aftonbladet:
\n– Flitet se mund t\u00eb miratohet n\u00eb Evrop\u00eb n\u00eb vitin 2024.<\/p>\n
<\/p>\n
![\"\"](\"https:\/\/neutrale.al\/wp-content\/uploads\/2023\/01\/2C2CF1C2-2AB5-42C2-94C3-61BE2DE9BE72-300x208.jpeg\")
<\/p>\n","protected":false},"excerpt":{"rendered":"
Mbr\u00ebmjen e s\u00eb premtes von\u00eb, mesazhi erdhi nga Agjencia Amerikane e Barnave, FDA. N\u00eb pak m\u00eb shum\u00eb se dy jav\u00eb, ai mund t\u00eb dal\u00eb n\u00eb treg n\u00eb vend. Nj\u00eb ila\u00e7 i ri suedez q\u00eb duhet t\u00eb jet\u00eb n\u00eb gjendje t\u00eb ngadal\u00ebsoj\u00eb s\u00ebmundjen e Alzheimerit \u00ebsht\u00eb vler\u00ebsuar n\u00eb Shtetet e Bashkuara. Nj\u00eb ila\u00e7 i ri suedez […]<\/p>\n","protected":false},"author":2,"featured_media":35979,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[27],"class_list":{"0":"post-35976","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-bota","8":"tag-lajme"},"_links":{"self":[{"href":"https:\/\/neutrale.al\/index.php\/wp-json\/wp\/v2\/posts\/35976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neutrale.al\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neutrale.al\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neutrale.al\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neutrale.al\/index.php\/wp-json\/wp\/v2\/comments?post=35976"}],"version-history":[{"count":1,"href":"https:\/\/neutrale.al\/index.php\/wp-json\/wp\/v2\/posts\/35976\/revisions"}],"predecessor-version":[{"id":35980,"href":"https:\/\/neutrale.al\/index.php\/wp-json\/wp\/v2\/posts\/35976\/revisions\/35980"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neutrale.al\/index.php\/wp-json\/wp\/v2\/media\/35979"}],"wp:attachment":[{"href":"https:\/\/neutrale.al\/index.php\/wp-json\/wp\/v2\/media?parent=35976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neutrale.al\/index.php\/wp-json\/wp\/v2\/categories?post=35976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neutrale.al\/index.php\/wp-json\/wp\/v2\/tags?post=35976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}